6-ethyl-3-(1h-tetrazol-5-yl)chromone has been researched along with 5-deazaflavin in 1 studies
Studies (6-ethyl-3-(1h-tetrazol-5-yl)chromone) | Trials (6-ethyl-3-(1h-tetrazol-5-yl)chromone) | Recent Studies (post-2010) (6-ethyl-3-(1h-tetrazol-5-yl)chromone) | Studies (5-deazaflavin) | Trials (5-deazaflavin) | Recent Studies (post-2010) (5-deazaflavin) |
---|---|---|---|---|---|
10 | 0 | 0 | 45 | 0 | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Althuis, TH; Hess, HJ; Moore, PF | 1 |
1 other study(ies) available for 6-ethyl-3-(1h-tetrazol-5-yl)chromone and 5-deazaflavin
Article | Year |
---|---|
Development of ethyl 3,4-dihydro-4-oxopyrimido[4,5-b]quinoline-2-carboxylate, a new prototype with oral antiallergy activity.
Topics: Animals; Anti-Inflammatory Agents; Cromolyn Sodium; Histamine Antagonists; Male; Passive Cutaneous Anaphylaxis; Pyridines; Quinolinic Acids; Rats; Structure-Activity Relationship | 1979 |